{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:28:03Z","timestamp":1791836883628,"version":"4.3.4"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The development and progression of immune-mediated rheumatic disease (IMRD) involves dysfunction of innate and adaptive immune cell populations leading to altered responses including inflammasome activation, dysregulated cytokine networks, increased immune cell numbers and multifaceted cell-cell communication. Several rheumatic diseases are further characterized by the presence of autoantibodies, immune complex mediated complement activation and the deficit of peripheral immune tolerance due to reduced regulatory T-lymphocyte cell function. Ultimately, in rheumatic disease the loss in cellular and tissue homeostasis culminates in the advancement of chronic inflammation. The three members of the NR4A subfamily of nuclear receptors are immediate early genes, and act as potent transcriptional responders to changes in the cellular and tissue microenvironment. Subfamily members are rapidly expressed in diseases characterized by inflammation and function to control the differentiation and activity of innate and adaptive immune cells in a cell-type and cell-context specific manner. Rheumatic disease including rheumatoid-, psoriatic-, osteo-arthritis and systemic sclerosis display altered NR4A1-3 activity in controlling immune cell migration and function, production of paracrine signaling molecules, synovial tissue hyperplasia, and regulating cartilage turn-over <jats:italic>in vivo<\/jats:italic>. Additionally, NR4A1-3 activities mediate cytokine, prostanoid and growth factor signaling to control angiogenesis, modulate the regulatory functions of mesenchymal stromal cells, alter the activation status of dendritic cells, influence the generation of peripheral myeloid and T-lymphocyte lineages and promote the maintenance of functional regulatory T-cells. Further reports uncover the potential of moderating NR4A 1-3 receptors as therapeutic targets in altering immune tolerance, pathological angiogenesis and controlling inflammation in several models of disease.<\/jats:p>","DOI":"10.3389\/fmed.2022.874182","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T13:50:59Z","timestamp":1658497859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Evelyn P.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Crean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and treatment of hip and knee osteoarthritis: a review","volume":"325","author":"Katz","year":"2021","journal-title":"Jama."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.3390\/ijms222413670","article-title":"Shaping of monocyte-derived dendritic cell development and function by environmental factors in Rheumatoid arthritis","volume":"22","author":"Coutant","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101519","DOI":"10.1016\/j.smim.2021.101519","article-title":"Cellular and molecular diversity in Rheumatoid arthritis","volume":"53","author":"Rivellese","year":"2022","journal-title":"Semin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers."},{"key":"B9","doi-asserted-by":"publisher","first-page":"73529","DOI":"10.18632\/oncotarget.19867","article-title":"Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-\u03b21-CTGF-VEGF functional module in rheumatoid arthritis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget."},{"key":"B10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"607186","DOI":"10.3389\/fmed.2020.607186","article-title":"The damage-associated molecular patterns (DAMPs) as potential targets to treat osteoarthritis: perspectives from a review of the literature","volume":"7","author":"Lambert","year":"2020","journal-title":"Front Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/acr2.11296","article-title":"Patterns of T-cell phenotypes in rheumatic diseases from single-cell studies of tissue","volume":"3","author":"Gao","year":"2021","journal-title":"ACR Open Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/cells10113017","article-title":"Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies","volume":"10","author":"Mueller","year":"2021","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B15","doi-asserted-by":"publisher","first-page":"655477","DOI":"10.3389\/fimmu.2021.655477","article-title":"A Tale of two immune cells in rheumatoid arthritis: the crosstalk between macrophages and T cells in the synovium","volume":"12","author":"Tu","year":"2021","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2147\/BTT.S252575","article-title":"Biological therapies for Rheumatoid arthritis: an overview for the clinician","volume":"15","author":"Findeisen","year":"2021","journal-title":"Biologics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"103620","DOI":"10.1016\/j.isci.2021.103620","article-title":"Rho GTPase signaling in rheumatic diseases","volume":"25","author":"Zeng","year":"2022","journal-title":"iScience."},{"key":"B18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41584-020-00523-9","article-title":"Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines","volume":"17","author":"Arden","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrrheum.2013.44","article-title":"Biologic agents in osteoarthritis: hopes and disappointments","volume":"9","author":"Chevalier","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.semarthrit.2016.12.001","article-title":"Biologic drugs as analgesics for the management of osteoarthritis","volume":"46","author":"Dimitroulas","year":"2017","journal-title":"Semin Arthritis Rheum."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo","year":"2021","journal-title":"Drug Des Devel Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.joca.2021.10.003","article-title":"Osteoarthritis year in review 2021: epidemiology & therapy","volume":"30","author":"Quicke","year":"2022","journal-title":"Osteoarthritis Cartilage."},{"key":"B23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaci.2021.08.010","article-title":"The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions","volume":"148","author":"Fragoulis","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/art.41906","article-title":"A Decade of JAK inhibitors: what have we learned and what may be the future?","volume":"73","author":"Liu","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"173238","DOI":"10.1016\/j.ejphar.2020.173238","article-title":"Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: effect of the novel JAK inhibitor peficitinib","volume":"882","author":"Emori","year":"2020","journal-title":"Eur J Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1182\/blood-2004-08-3072","article-title":"Balance between NF-kappaB and JNK\/AP-1 activity controls dendritic cell life and death","volume":"106","author":"Kriehuber","year":"2005","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.molcel.2017.08.006","article-title":"Static and dynamic DNA loops form AP-1-bound activation hubs during macrophage development","volume":"67","author":"Phanstiel","year":"2017","journal-title":"Mol Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"3","author":"Tanaka","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","article-title":"Toll-like receptors and chronic inflammation in rheumatic diseases: new developments","volume":"12","author":"Joosten","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","article-title":"NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis","volume":"14","author":"Roman-Blas","year":"2006","journal-title":"Osteoarthritis Cartilage."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13317-020-00135-z","article-title":"NF-\u03baB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes","volume":"11","author":"Nejatbakhsh Samimi","year":"2020","journal-title":"Auto Immun Highlights."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.2012.01111.x","article-title":"Celebrating 25 years of NF-\u03baB research","volume":"246","author":"Ghosh","year":"2012","journal-title":"Immunol Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsbmb.2015.04.016","article-title":"Nuclear receptor 4A (NR4A) family - orphans no more","volume":"157","author":"Safe","year":"2016","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"15639","DOI":"10.1021\/acs.jmedchem.0c00894","article-title":"Assessment of NR4A ligands that directly bind and modulate the orphan nuclear receptor Nurr1","volume":"63","author":"Munoz-Tello","year":"2020","journal-title":"J Med Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1042\/EBC20200164","article-title":"Orphan nuclear receptor 4A1 (NR4A1) and novel ligands","volume":"65","author":"Safe","year":"2021","journal-title":"Essays Biochem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/biom5031302","article-title":"Molecular Interactions between NR4A orphan nuclear receptors and NF-\u03baB Are required for appropriate inflammatory responses and immune cell homeostasis","volume":"5","author":"Murphy","year":"2015","journal-title":"Biomolecules."},{"key":"B39","doi-asserted-by":"publisher","first-page":"589770","DOI":"10.3389\/fcell.2021.589770","article-title":"Targeting NR4A nuclear receptors to control stromal cell inflammation, metabolism, angiogenesis, and tumorigenesis","volume":"9","author":"Crean","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"624122","DOI":"10.3389\/fendo.2020.624122","article-title":"Role of the orphan nuclear receptor NR4A family in T-cell biology","volume":"11","author":"Odagiu","year":"2020","journal-title":"Front Endocrinol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.it.2019.12.006","article-title":"Nuclear receptors in cancer inflammation and immunity","volume":"41","author":"Zhao","year":"2020","journal-title":"Trends Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/cells9122606","article-title":"Nuclear hormone receptors and their ligands: metabolites in control of transcription","volume":"9","author":"Tao","year":"2020","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.beem.2015.07.005","article-title":"Classical nuclear hormone receptor activity as a mediator of complex biological responses: a look at health and disease","volume":"29","author":"Yen","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1210\/er.2018-00222","article-title":"Nuclear receptors: recent drug discovery for cancer therapies","volume":"40","author":"Zhao","year":"2019","journal-title":"Endocr Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/cells8111373","article-title":"Function of Nr4a orphan nuclear receptors in proliferation, apoptosis and fuel utilization across tissues","volume":"8","author":"Herring","year":"2019","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1021\/acsptsci.8b00029","article-title":"Advances in orphan nuclear receptor pharmacology: a new era in drug discovery","volume":"1","author":"de Vera","year":"2018","journal-title":"ACS Pharmacol Transl Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1016\/j.bbamcr.2014.06.010","article-title":"NR4A nuclear receptors are orphans but not lonesome","volume":"1843","author":"Kurakula","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1042\/BCJ20190253","article-title":"Molecular, chemical, and structural characterization of prostaglandin A2 as a novel agonist for Nur77","volume":"476","author":"Lakshmi","year":"2019","journal-title":"Biochem J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1021\/acschembio.6b00037","article-title":"Identification of a binding site for unsaturated fatty acids in the orphan nuclear receptor Nurr1","volume":"11","author":"de Vera","year":"2016","journal-title":"ACS Chem Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3109\/10799893.2014.948555","article-title":"The NR4A orphan nuclear receptors: mediators in metabolism and diseases","volume":"35","author":"Ranhotra","year":"2015","journal-title":"J Recept Signal Transduct Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1042\/EBC20210004","article-title":"Nuclear receptor Nur77: its role in chronic inflammatory diseases","volume":"65","author":"Lith","year":"2021","journal-title":"Essays Biochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/14728222.2017.1279146","article-title":"The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases","volume":"21","author":"Rodr\u00edguez-Calvo","year":"2017","journal-title":"Expert Opin Ther Targets."},{"key":"B53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4049\/jimmunol.175.1.555","article-title":"Modulation of orphan nuclear receptor NURR1 expression by methotrexate in human inflammatory joint disease involves adenosine A2A receptor-mediated responses","volume":"175","author":"Ralph","year":"2005","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-9195-2_3","article-title":"Subcellular localization of NR4A2 orphan nuclear receptor expression in human and mouse synovial joint tissue","volume":"1966","author":"Smyth","year":"2019","journal-title":"Methods Mol Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.jid.5701023","article-title":"Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition","volume":"128","author":"O'Kane","year":"2008","journal-title":"J Invest Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajpath.2013.06.029","article-title":"Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity","volume":"183","author":"McMorrow","year":"2013","journal-title":"Am J Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3777.Epub","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/art.34399","article-title":"Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription","volume":"64","author":"Mix","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1042\/BST0390688","article-title":"Inflammation: a role for NR4A orphan nuclear receptors?","volume":"39","author":"McMorrow","year":"2011","journal-title":"Biochem Soc Trans."},{"key":"B60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jbspin.2015.09.001","article-title":"Identification of upstream regulators for synovial expression signature genes in osteoarthritis","volume":"83","author":"Fei","year":"2016","journal-title":"Joint Bone Spine."},{"key":"B61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/ITT.S288547","article-title":"Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology","volume":"10","author":"Unterberger","year":"2021","journal-title":"Immunotargets Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11926-009-0051-z","article-title":"The role of toll-like receptors in rheumatoid arthritis","volume":"11","author":"Huang","year":"2009","journal-title":"Curr Rheumatol Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s11658-020-00241-w","article-title":"The nuclear receptor 4A family members: mediators in human disease and autophagy","volume":"25","author":"Chen","year":"2020","journal-title":"Cell Mol Biol Lett."},{"key":"B64","doi-asserted-by":"publisher","first-page":"835697","DOI":"10.3389\/fphar.2022.835697","article-title":"Orphan nuclear receptor NR4A2 is constitutively expressed in cartilage and upregulated in inflamed synovium from hTNF-Alpha transgenic mice","volume":"13","author":"Lilley","year":"2022","journal-title":"Front Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.molimm.2009.07.019","article-title":"Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis","volume":"46","author":"Aherne","year":"2009","journal-title":"Mol Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-9255-2-15","article-title":"Nurr1 dependent regulation of pro-inflammatory mediators in immortalised synovial fibroblasts","volume":"2","author":"Davies","year":"2005","journal-title":"J Inflamm (Lond)."},{"key":"B67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12950-015-0059-2","article-title":"Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin","volume":"12","author":"McCoy","year":"2015","journal-title":"J Inflamm (Lond)."},{"key":"B68","doi-asserted-by":"publisher","first-page":"24261","DOI":"10.18632\/oncotarget.4637","article-title":"Requirement of novel amino acid fragments of orphan nuclear receptor TR3\/Nur77 for its functions in angiogenesis","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget."},{"key":"B69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.14-257550","article-title":"Orphan nuclear receptor TR3\/Nur77 improves wound healing by upregulating the expression of integrin \u03b24","volume":"29","author":"Niu","year":"2015","journal-title":"FASEB J."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood-2012-07-443903","article-title":"The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3\/Nur77 and subsequently truncate it through thrombospondin-1","volume":"121","author":"Qin","year":"2013","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","first-page":"103934","DOI":"10.1016\/j.mvr.2019.103934","article-title":"Orphan nuclear receptor TR3\/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells","volume":"128","author":"Chen","year":"2020","journal-title":"Microvasc Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mvr.2018.10.011","article-title":"Orphan nuclear receptor TR3\/Nur77 differentially regulates the expression of integrins in angiogenesis","volume":"122","author":"Ye","year":"2019","journal-title":"Microvasc Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"12066","DOI":"10.1073\/pnas.1018438108","article-title":"Orphan nuclear transcription factor TR3\/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions","volume":"108","author":"Zhao","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B74","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1084\/jem.20051523","article-title":"Orphan nuclear receptor TR3\/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity","volume":"203","author":"Zeng","year":"2006","journal-title":"J Exp Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/ijms22041600","article-title":"Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes","volume":"22","author":"Medzikovic","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1159\/000488838","article-title":"NR4A1 is involved in fibrogenesis in ovarian endometriosis","volume":"46","author":"Zeng","year":"2018","journal-title":"Cell Physiol Biochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/eji.202048869","article-title":"'Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity","volume":"50","author":"Lith","year":"2020","journal-title":"Eur J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2013.03.010","article-title":"Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal","volume":"153","author":"Carlin","year":"2013","journal-title":"Cell."},{"key":"B79","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/ni.2063","article-title":"The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes","volume":"12","author":"Hanna","year":"2011","journal-title":"Nat Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.jid.2019.04.006","article-title":"Intervention of inflammatory monocyte activity limits dermal fibrosis","volume":"139","author":"Haub","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","article-title":"NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis","volume":"110","author":"Hanna","year":"2012","journal-title":"Circ Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/eji.201646406","article-title":"NR4A1-dependent Ly6C(low) monocytes contribute to reducing joint inflammation in arthritic mice through Treg cells","volume":"46","author":"Brunet","year":"2016","journal-title":"Eur J Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"676644","DOI":"10.3389\/fimmu.2021.676644","article-title":"Transcriptional profiling of monocytes deficient in nuclear orphan receptors NR4A2 and NR4A3 Reveals distinct signalling roles related to antigen presentation and viral response","volume":"12","author":"Phelan","year":"2021","journal-title":"Front Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3389\/fimmu.2018.01797","article-title":"Nuclear receptor Nur77 deficiency alters dendritic cell function","volume":"9","author":"Tel-Karthaus","year":"2018","journal-title":"Front Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.4049\/jimmunol.1601911","article-title":"The orphan nuclear receptor NR4A3 is involved in the function of dendritic cells","volume":"199","author":"Nagaoka","year":"2017","journal-title":"J Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1172\/JCI87081","article-title":"The transcription factor NR4A3 controls CD103+ dendritic cell migration","volume":"126","author":"Park","year":"2016","journal-title":"J Clin Invest."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/eji.201546229","article-title":"Nuclear receptor expression atlas in BMDCs: Nr4a2 restricts immunogenicity of BMDCs and impedes EAE","volume":"46","author":"Saini","year":"2016","journal-title":"Eur J Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.1073\/pnas.1821296116","article-title":"The orphan nuclear receptor NR4A3 controls the differentiation of monocyte-derived dendritic cells following microbial stimulation","volume":"116","author":"Boulet","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.20142088","article-title":"Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells","volume":"212","author":"Sekiya","year":"2015","journal-title":"J Exp Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ni.2520","article-title":"Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis","volume":"14","author":"Sekiya","year":"2013","journal-title":"Nat Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1172\/jci.insight.151005","article-title":"NR4A family members regulate T cell tolerance to preserve immune homeostasis and suppress autoimmunity","volume":"6","author":"Hiwa","year":"2021","journal-title":"JCI Insight"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/25785826.2019.1698261","article-title":"Memory T cell, exhaustion, and tumor immunity","volume":"43","author":"Ando","year":"2020","journal-title":"Immunol Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The immunological genome project: networks of gene expression in immune cells","volume":"9","author":"Heng","year":"2008","journal-title":"Nat Immunol."},{"key":"B94","unstructured":"700310.1038\/s41590-020-0687-432577013Nat Immunol212020"},{"key":"B95","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4049\/immunohorizons.1900043","article-title":"An accord of nuclear receptor expression in CD4+ T Cells in Rheumatoid arthritis","volume":"3","author":"Saini","year":"2019","journal-title":"Immunohorizons."},{"key":"B96","doi-asserted-by":"publisher","first-page":"110766","DOI":"10.1016\/j.celrep.2022.110766","article-title":"Accelerating medicines partnership Rheumatoid arthritis and systemic lupus erythematosus (AMP RA\/SLE) consortium, McDavid A, Anolik JH. Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression","volume":"39","author":"Meednu","year":"2022","journal-title":"Cell Rep"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/art.39745","article-title":"Review: neutrophils as invigorated targets in rheumatic diseases","volume":"68","author":"Grayson","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e108553","DOI":"10.1371\/journal.pone.0108553","article-title":"Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways","volume":"9","author":"Ericson","year":"2014","journal-title":"PLoS ONE."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood-2017-03-770164","article-title":"NR4A orphan nuclear receptor family members, NR4A2 and NR4A3, regulate neutrophil number and survival","volume":"130","author":"Prince","year":"2017","journal-title":"Blood."},{"key":"B100","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1182\/blood-2017-07-793380","article-title":"NR4A proteins and neutrophil lifespan","volume":"130","author":"Allen","year":"2017","journal-title":"Blood."},{"key":"B101","doi-asserted-by":"publisher","first-page":"9492","DOI":"10.1074\/jbc.M608327200","article-title":"Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage","volume":"282","author":"Mix","year":"2007","journal-title":"J Biol Chem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1002\/art.34554","article-title":"Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes","volume":"64","author":"Marzaioli","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B103","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fcell.2020.00158","article-title":"Reactivation of nr4a1 restrains chondrocyte inflammation and ameliorates osteoarthritis in rats","volume":"8","author":"Xiong","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jcmm.14804","article-title":"The pro-inflammatory effect of NR4A3 in osteoarthritis","volume":"24","author":"Ma","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1038\/s41598-020-59469-3","article-title":"Targeting oncogenic super enhancers in MYC-dependent AML using a small molecule activator of NR4A nuclear receptors","volume":"10","author":"Call","year":"2020","journal-title":"Sci Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41375-018-0174-1","article-title":"Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia","volume":"33","author":"Boudreaux","year":"2019","journal-title":"Leukemia."},{"key":"B107","doi-asserted-by":"publisher","first-page":"715894","DOI":"10.3389\/fimmu.2021.715894","article-title":"Critical role of synovial tissue-resident macrophage and fibroblast subsets in the persistence of joint inflammation","volume":"12","author":"Kemble","year":"2021","journal-title":"Front Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1158\/1541-7786.MCR-20-0707","article-title":"the paradoxical roles of orphan nuclear receptor 4A (NR4A) in cancer","volume":"19","author":"Safe","year":"2021","journal-title":"Mol Cancer Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"111880","DOI":"10.1016\/j.biopha.2021.111880","article-title":"Topical nanocarriers for management of Rheumatoid arthritis: a review","volume":"141","author":"Anita","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv Drug Deliv Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov."},{"key":"B112","doi-asserted-by":"publisher","first-page":"686155","DOI":"10.3389\/fimmu.2021.686155","article-title":"Promising therapeutic targets for treatment of Rheumatoid arthritis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jcyt.2021.10.003","article-title":"Rheumatoid arthritis: from synovium biology to cell-based therapy","volume":"24","author":"Debreova","year":"2022","journal-title":"Cytotherapy"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/ijms222111592","article-title":"Mesenchymal stem cell-based therapy for Rheumatoid arthritis","volume":"22","author":"Sarsenova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/cells9081852","article-title":"Mesenchymal stem\/stromal cells for rheumatoid arthritis treatment: an update on clinical applications","volume":"9","author":"Lopez-Santalla","year":"2020","journal-title":"Cells."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910197","article-title":"Stem cells in autologous microfragmented adipose tissue: current perspectives in osteoarthritis disease","author":"De Francesco","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.3390\/ijms22157970","article-title":"Regulatory macrophages and tolerogenic dendritic cells in myeloid regulatory cell-based therapies","volume":"22","author":"Suuring","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"643240","DOI":"10.3389\/fimmu.2021.643240","article-title":"Tolerogenic immunotherapy: targeting DC surface receptors to induce antigen-specific tolerance","volume":"12","author":"Castenmiller","year":"2021","journal-title":"Front Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cei.12038","article-title":"Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?","volume":"172","author":"Hilkens","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"103427","DOI":"10.1016\/j.ebiom.2021.103427","article-title":"Mesenchymal stem\/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies","volume":"69","author":"Lopez-Santalla","year":"2021","journal-title":"EBioMedicine."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.874182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T13:51:03Z","timestamp":1658497863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.874182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":122,"alternative-id":["10.3389\/fmed.2022.874182"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.874182","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"874182"}}